
    
      All patients entering this study will initially undergo combined modality treatment with
      concurrent radiation therapy + temozolomide. Four weeks after completing radiation therapy,
      patients will begin 6 months of follow-up treatment with oral temozolomide plus sorafenib.

      Combined Modality Therapy - Radiation Therapy Radiotherapy must begin within â‰¤ 6 weeks of
      surgery. One treatment of 2.0Gy will be given daily 5 days per week for a total of 60.0Gy
      over 6 weeks. Temozolomide 75mg/m2 PO will be given daily, beginning on the first day of
      radiation therapy and continuing through the last day of radiation therapy.

      After completion of combined modality therapy, patients will have 4 weeks without any
      therapy.

      Systemic Therapy Beginning 4 weeks after the completion of radiation therapy, patients will
      receive 6 months of treatment with temozolomide and sorafenib. Temozolomide 150mg/m2 orally
      will be administered days 1-5, and repeated every 28 days for 6 courses. Sorafenib 400mg PO
      bid will be administered on days 1-28, repeated for 6 courses concurrently with temozolomide
    
  